Search clinical trials for: Resected

Total 261 results

H. Lee Moffitt Cancer Center and Research Institute
GlaxoSmithKline; Oncovir, Inc.

Terminated

Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC

Melanoma

United States
Duke University

Completed

Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer (TOP 1502)

Non-small Cell Lung Carcinoma

United States
Hoffmann-La Roche

Completed

A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma (BRIM8)

Melanoma

United States, Israel, Italy, Spain, Belgium, United Kingdom, Austria, Czechia, France, Netherlands, New Zealand, Russian Federation, Australia, Canada, Croatia, Portugal, Germany, Ukraine, Switzerland, Argentina, Brazil, Ireland, N... and more
Augusta University

Terminated

Gemcitabine and CT-011 for Resected Pancreatic Cancer

Pancreatic Neoplasms | Pancreatic Cancer | Pancreas Cancer | Cancer of the Pancreas | Neoplasms Pancreatic

United States
TriHealth Inc.

Completed

Accuracy of Endoscopists in Predicting Polyp Pathology

Resected Polyp

United States
The University of Texas Health Science Center at...

Withdrawn

Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer

Bladder Cancer

United States
Grupo de Investigación Clínica en Oncología Radioterapia

Completed

Erlotinib,Radiation and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma of the Head and Neck

Spain
University of Rome Tor Vergata

Completed

Impact of Resected Gastric Volume on Postoperative Weight Loss After Laparoscopic Sleeve Gastrectomy for Morbid Obesity

Morbid Obesity
Chang Gung Memorial Hospital

Unknown

Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+

Squamous Cell Carcinoma of Oral Cavity

Taiwan
University Hospital, Grenoble
Clinical Investigation Centre for Innovative Technology Network; TIMC-IMAG

Terminated

Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection (Bio-Prost)

Cancer Prostate

France
Yonsei University

Completed

Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic Cancer

Pancreatic Cancer

Korea, Republic of
Yonsei University

Unknown

A Phase III, Randomized, Multi-center Study to Determine the Efficacy of the Intercalating Combination Treatment of Chemotherapy and Gefitinib or Chemotherapy as Adjuvant Treatment in NSCLC With Common EGFR Mutations.

Completely Resected NSCLC With Common EGFR Mutations

Korea, Republic of
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck

Head and Neck Cancer

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Genentech, Inc.

Completed

Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR

Non-small Cell Lung Cancer

United States
University Health Network, Toronto

Completed

Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma

Non-small Cell Lung Cancer

Canada
Guangdong Association of Clinical Trials

Unknown

A Non-interventional Retrospective Study on Overall Survival in Completely Resected Chinese NSCLC Patients With Adenocarcinoma Histology- ICAN Extension Study

Overall Survival
Herlev Hospital
GENIS

Terminated

Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (CHIPAC)

Pancreatic Cancer

Denmark
BrightPath Biotherapeutics

Completed

Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma

Melanoma

United States
Stanford University

Withdrawn

Lidocaine-Prilocaine Cream in Conjunction With Paracervical Block for Pain With Abortion

Pain

United States
University of California, Irvine
Sanofi

Terminated

Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer

Head and Neck Cancer

United States
Sanjiv Agarwala, MD
Merck Sharp & Dohme LLC

Unknown

A Study to Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma

Melanoma

United States
University of Louisville

Withdrawn

A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma

United States
Peking University Cancer Hospital & Institute

Unknown

HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma

Melanoma

China
European Institute of Oncology

Terminated

MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients (MelaViD)

Melanoma

Italy
Tokyo University
Shionogi; National Cancer Center Hospital East; Hokkaido University; Fukushima... and other collaborators

Unknown

Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer

Non-small- Cell Lung Cancer

Japan
Columbia University

Withdrawn

Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLC

Non-small Cell Lung Cancer
Klinikum der Universitaet Muenchen, Grosshadern
Ludwig-Maximilians - University of Munich; The European Society for Hyperthermic...

Unknown

Hyperthermia European Adjuvant Trial (HEAT)

Resected Pancreatic Adenocarcinoma

Germany
Clinica Universidad de Navarra, Universidad de...

Unknown

Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma

Colorectal Carcinoma | Hepatic Metastasis

Spain
UNC Lineberger Comprehensive Cancer Center
Aventis Pharmaceuticals

Completed

Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC

Lung Cancer

United States
University of Alabama at Birmingham
Pfizer; Pharmacia

Completed

Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib (UAB0040)

Colorectal Adenoma | Colorectal Carcinoma

United States
Novartis Pharmaceuticals

Completed

Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST) (INV555)

Gastrointestinal Stromal Tumors

Saudi Arabia, Taiwan, Turkey, Egypt, Thailand, Russian Federation, South Africa, Lebanon, India, Tunisia, Algeria, Jordan
Istituto Clinico Humanitas
Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)

Unknown

Surgically Resected Crohn's Disease Patients: Prognostic Factors for Re-operation and New Score Building (POCD2017)

Crohn Disease

Italy
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma

Recurrent Melanoma

United States
Novartis Pharmaceuticals
University of Sheffield; Danish Breast Cancer Cooperative Group

Completed

A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer

Hormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women

Denmark, United Kingdom
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients (ProphyloCHIP)

Colorectal Cancer With a Resected Minimal Synchronous PC | Ovarian Metastases | Tumour Rupture in the Abdominal Cavity

France
Baylor Research Institute
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma

Malignant Melanoma Stage III | Malignant Melanoma Stage IV

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer

Pancreatic Cancer

United States
Dong-A University

Completed

Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic Keratosis

Actinic Dermatosis

Korea, Republic of
Hoffmann-La Roche

Terminated

A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer

Head and Neck Cancer

Spain
Hoffmann-La Roche

Completed

A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer

Colorectal Cancer

Bulgaria
Emory University

Terminated

Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision

Pancreatic Neoplasms | Pancreatic Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Determine Toxicity and Antibody Responses With a KLH Conjugated Bivalent Vaccine Containing GD2 Lactone, GD3 Lactone With Immunological Adjuvant QS-DG or OPT-821 in Patients With Disease Free AJCC Stage III or IV Cutaneous Melanoma

Melanoma

United States
Herbert J. Zeh, III MD, FACS
Genentech, Inc.

Terminated

A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer

Pancreatic Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
The John P. Hussman Foundation

Completed

Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma

Melanoma

United States
Cliniques universitaires Saint-Luc- Université...
Grand Hôpital de Charleroi

Terminated

Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors

Metastatic Colorectal Cancer

Belgium
Craig L Slingluff, Jr
GlaxoSmithKline

Completed

Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI (Mel55)

Melanoma

United States
NYU Langone Health
Food and Drug Administration (FDA)

Completed

Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer

Stomach Cancer | Gastric Cancer

United States
King Faisal Specialist Hospital & Research Center
Radiation Therapy Oncology Group

Completed

A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors

Malignant Salivary Gland Tumors

Saudi Arabia
University of Pittsburgh
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer

Pancreatic Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus

Uterine Cancer | Uterine Leiomyosarcoma

United States

Search clinical trials for: Resected

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations